Cypherpunk Technologies Inc(CYPH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:59 PM ET (Korea 10/31 08:59)
Full metrics table
| Index | - | P/E | 5.27 | EPS (ttm) | 0.57 | Insider Own | 35% | Shs Outstand | 107.8M | Perf Week | 5.67% |
| Market Cap | 0.32B | Forward P/E | 7.1 | EPS next Y | - | Insider Trans | -0.63% | Shs Float | 70.0M | Perf Month | 2.05% |
| Enterprise Value | 0.31B | PEG | 0.05 | EPS next Q | 0.03 | Inst Own | 14.66% | Short Float | 21.07% | Perf Quarter | 367.96% |
| Income | -0.00B | P/S | - | EPS this Y | -100% | Inst Trans | 12.79% | Short Ratio | 1.19 | Perf Half Y | 206.17% |
| Sales | 0.00B | P/B | 2.31 | EPS next 5Y | 133.4% | ROA | -1.08% | Short Interest | 14.76M | Perf YTD | 156.9% |
| Book/sh | 1.29 | P/C | 42.14 | EPS past 3/5Y | - | ROE | -1.21% | 52W High | -28.88% ($4.19) | Perf Year | 549.24% |
| Cash/sh | 0.07 | P/FCF | - | Sales past 3/5Y | - | ROIC | -0.63% | 52W Low | 658.27% ($0.39) | Perf 3Y | 102.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 137.89% | Gross Margin | - | Volatility(W/M) | 11.56% 13.09% | Perf 5Y | -89.32% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.43 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 79.19 | EPS Q/Q | 145.12% | Profit Margin | - | RSI (14) | 50.96 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 79.19 | Sales Q/Q | - | SMA20 | 0.77% ($2.96) | Beta | 1.07 | Target Price | $4.15 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/12 | SMA50 | 8.57% ($2.74) | Rel Volume | 1.16 | Prev Close | $3.31 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 700% - | SMA200 | 132.68% ($1.28) | Avg Volume(3M) | 12.39M | Price | $2.98 |
| IPO | 2017/1/25 | Option/Short | Yes/Yes | Trades | 14742 | Volume | 14,408,268 | Change | -9.97% |
🔐 A US-listed company that combines investment in and discovery of privacy-enhancing technologies with a digital-asset accumulation strategy centered on Zcash. It also retains oncology drug-development assets inherited from a predecessor company, giving it an unusual structure: although classified as a biotech, its digital-asset treasury strategy serves as a core pillar of corporate value.
Over the past 1 year, roughly in the middle
29% below its 1-year high.
Traded about as much as usual. That is 116% of its average volume.
CYPH has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -100.0% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $710. Peers typically go for $756.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -89.3%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
21.1% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #83 of 137 in the industry
Based on market cap of $321M.
CION#81 CION Invt Corp $344M PER 116.7 CYPH#83 Cypherpunk Technologies Inc $321M PER 5.3 
KWY#86 Kingsway Corp $284M PER - 
RWAY#87 Runway Growth Finance Corp $273M PER 60.4 
HRZN#88 Horizon Technology Finance Corp $273M PER 12.4 
FAQ
What kind of company is CYPH?
CYPH belongs to the Financial sector and operates in the Asset Management industry.
What is the market cap of CYPH?
The market cap of CYPH is approximately $321M, ranking 3,559 within its sector.
What is the P/E ratio of CYPH?
CYPH has a P/E ratio of approximately 5.3x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CYPH?
CYPH has recorded a 52-week high of $4.19 and a low of $0.39.
